We are pleased to inform you about new hepatitis C virus (HCV) genotypes differentiation PCR kit. The kits of these series intend for an in vitro nucleic acid amplification test for qualitative detection and differentiation of hepatitis C virus (HCV) genotypes in the clinical materials (peripheral blood plasma) by means of real-time hybridization-fluorescence detection.
New! AmpliSens® HCV-genotype-FRT-g1-6 is intended to detect HCV genotypes 1a, 1b, 2, 3a, 4, 5a, and 6.
The variant AmpliSens® HCV-genotype-FRT-g1-4 is intended to detect HCV genotypes 1a, 1b, 2, 3a, and 4.
AmpliSens® HCV-genotype-FRT PCR kit is recommended for use after detection of hepatitis C virus RNA by qualitative or quantitative analysis with the use of PCR kits manufactured by FBIS CRIE (for example, AmpliSens® HCV-FRT (real-time hybridization-fluorescence detection), AmpliSens® HCV-FEP (end-point hybridization-fluorescence detection), or AmpliSens® HCV-EPh (electrophoretic detection in agarose gel).
The results of PCR analysis are taken into account in complex diagnostics of disease.